CHARLES RIVER LABORATORIES INTERNATIONAL INC
10-Q, EX-27, 2000-08-08
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CHARLES RIVER LABORATORIES INTERNATIONAL INC, 10-Q, 2000-08-08
Next: CAYENTA INC, S-1/A, 2000-08-08



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM THE CONSOLIDATED
STATEMENT OF EARNINGS FOR THE SIX MONTHS ENDED JUNE 25, 2000 AND THE
CONSOLIDATED BALANCE SHEET AT MARCH 25, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-10-2000
<PERIOD-END>                               JUN-24-2000
<CASH>                                          18,993
<SECURITIES>                                         0
<RECEIVABLES>                                   50,930
<ALLOWANCES>                                       976
<INVENTORY>                                     32,192
<CURRENT-ASSETS>                               108,338
<PP&E>                                         117,741
<DEPRECIATION>                                 143,089
<TOTAL-ASSETS>                                 398,900
<CURRENT-LIABILITIES>                           67,078
<BONDS>                                        392,745
                                0
                                          0
<COMMON>                                           198
<OTHER-SE>                                   (108,663)
<TOTAL-LIABILITY-AND-EQUITY>                   398,900
<SALES>                                        143,399
<TOTAL-REVENUES>                               143,399
<CGS>                                           83,912
<TOTAL-COSTS>                                   83,912
<OTHER-EXPENSES>                                26,042
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              25,821
<INCOME-PRETAX>                                  8,145
<INCOME-TAX>                                     (396)
<INCOME-CONTINUING>                              8,541
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     8,610
<EPS-BASIC>                                        .43
<EPS-DILUTED>                                      .37


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission